A 26-year-old woman with debilitating juvenile rheumatoid arthritis was treated at a Mexican arthritis clinic with two unknown medications. She subsequently developed agranulocytosis and cholestatic hepatitis as an adverse reaction to these drugs, later identified as oxyphenbutazone and diazepam. The etiology of these drug-induced problems is reviewed, and the dangers of this unorthodox form of medical therapy are discussed.
EnglemanE.P., KruppM.A., RinehartJ.E.Hepatitis following the ingestion of phenylbutazone. JAMA1954; 156: 98–101.
6.
MacCarthyJ.M., JacksonR.I.Hepatic necrosis and other visceral lesions associated with phenylbutazone therapy. Br Med J1955; 2: 240–2.
7.
EckerJ.A.Phenylbutazone hepatitis. Am J Gastroenterol1965; 43: 23–9.
8.
IshakK.G., KirchnerJ.P., KharJ.K.Granulomas and cholestatic hepatocellular injury associated with phenylbutazone. Am J Dig Dis1977; 22: 611–7.
9.
BenjaminS.B., IshakK.G., ZimmermanH.J.Phenylbutazone liver injury: a clinical-pathologic survey of 23 cases and review of the literature. Hepatology1981; 1: 255–63.
10.
SuihovecJ.Anti-inflammatory analgesics and drugs used in gout. In: DukesM.N.G., ed. Meyler's side effects of drugs. 9th ed. Amsterdam: Excerpta Medica, 1980: 145.
